Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Trading Statement

9 Apr 2020 07:00

RNS Number : 2822J
First Derivatives PLC
09 April 2020
 

9 April 2020

 

First Derivatives plc

("FD" or the "Group")

 

Trading Update and Notice of Results

 

FD (AIM: FDP.L, Euronext Growth: FDP.I) announces that it continued to trade positively in the second half of the financial year ended 29 February 2020. As a result, the Board expects to report a financial performance in line with company-compiled consensus forecasts of ÂŁ241m of revenue and ÂŁ46m of adjusted EBITDA. Net debt at the period end was ÂŁ50m, which was better than the consensus forecast of ÂŁ56m.

 

COVID-19

 

The global operations of the Group enabled us to identify the business disruption threat of COVID-19 early, and we implemented our pandemic plan at the beginning of February across all regions in which we operate. A team led by CEO Seamus Keating and comprising senior leaders across FD coordinated the action, with the priorities of protecting the health and wellbeing of our employees and supporting our customers.

 

In FinTech, the Group supports mission-critical systems across the financial industry and in other markets our technology is key to the success of our customers. We contacted all our customers to minimise the impact of COVID-19 through various measures including remote working and are pleased that these are working without significant disruption to the business.

 

Impact to date

 

To date we have seen no financial impact from the effects of COVID-19. All our services delivery is now being conducted remotely, with no impact on revenue. In our managed services and consulting business the services that we provided prior to COVID-19 are now being delivered remotely with utilisation rates in March 2020 remaining in line with the prior month. We continue to monitor developments closely through close and regular contact with customers across all the markets in which we operate.

 

Potential impacts and mitigation

 

Looking ahead, our conversations with customers indicate that in the near-term there will be a lengthening of software sales cycles, at least until the impact of COVID-19 is clearer. The Group is protected to some extent by the breadth of its sales pipeline across multiple industries and geographies, while further reassurance is provided by the repeat and recurring nature of the majority of our software revenue.

 

In consulting and managed services, we continue to benefit from high levels of repeat revenue from the 'Business as Usual' operations of our capital markets clients. We are monitoring the impact of COVID-19 on new business, particularly with regard to project work implementing change programs.

 

As the macroeconomic impact of COVID-19 continues to grow, the Group has conducted a scenario testing exercise with a range of assumptions including a severe, extended downturn in economic activity. Under all such scenarios the Group remains profitable and cash generative.

 

Notwithstanding the assurance provided by our scenario testing, the Group has taken a range of measures to mitigate any future potential impact of COVID-19, including suspending non-essential business travel and short-term deferral of the summer graduate intake. In addition, the Executive Directors will not receive a bonus payment relating to the financial year ended 29 February 2020.

 

In order to preserve the Group's liquidity during this period, the Board will not recommend a final dividend in respect of the year to 29 February 2020.

 

Liquidity

 

As at 31 March 2020, FD had gross cash available to it of ÂŁ64m. This included ÂŁ35m of funds drawn down on 24 March 2020 from the Group's available finance facilities, with the funds placed on deposit to provide further comfort on liquidity should conditions deteriorate markedly. The Group has a further ÂŁ15m in undrawn revolving credit facilities available to it.

 

The Group has significant headroom on its covenants and taking into account the scenario testing and mitigating measures taken, expects that situation to persist through the impact of COVID-19, irrespective of its duration.

 

The strength of our business model and liquidity position provide us with the confidence to continue to invest across the Group, in line with our strategy.

 

Summary

 

The Group delivered continued solid growth in the financial year to 29 February 2020. We reacted quickly to help employees and customers minimise the impact of COVID-19. While there has been no financial impact to date, it is still too early to determine what impact may result, particularly if there is an extended period of economic disruption. We believe that the Group has acted prudently to mitigate any potential impact through a range of measures aimed at ensuring its ongoing financial liquidity.

 

In the longer term, FD remains confident in its strategy and in particular the growth in demand for its world-class Kx technology from both potential customers and partners.

 

Date of results

 

The Group will announce its full year results for the year ended 29 February 2020 on 19 May 2020. A briefing for analysts and investors will be held on the day and further details will be provided in due course.

 

Enquiries

For further information please contact:

 

First Derivatives plc

Seamus Keating, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc (Nominated Adviser and Broker)

Andrew Pinder

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 5970

 

 

Goodbody (Euronext Growth Adviser and Broker)

David Kearney

Don Harrington

Finbarr Griffin

 

+353 1 667 0420

 

 

 

FTI Consulting

Matt Dixon

Dwight Burden

Darius Alexander

 

+44 (0)20 3727 1000

 

 

About FD

FD is a global technology provider with more than 20 years of experience working with some of the world's largest finance, technology, automotive, utility, manufacturing and energy institutions. The Group's Kx technology, incorporating the kdb+ time-series database, is a leader in high-performance, in-memory computing, streaming analytics and operational intelligence. Kx delivers the best possible performance and flexibility for high-volume, data-intensive analytics and applications across multiple industries. FD operates from 15 offices across Europe, North America and Asia Pacific, including its headquarters in Newry, and employs more than 2,400 people worldwide.

 

For further information, please visit www.firstderivatives.com and www.kx.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFERSRITIII
Date   Source Headline
11th Feb 20144:18 pmRNSDirector's Shareholding
10th Feb 20147:00 amRNSIssue of Equity
6th Feb 20147:00 amRNSOpening of Singapore Office
20th Jan 20147:00 amRNSDirector/PDMR Shareholding
31st Dec 201311:08 amRNSTotal Voting Rights
20th Dec 20134:33 pmRNSIssue of Equity
5th Dec 20137:00 amRNSEnterprise Securities Market Notice
29th Nov 20134:00 pmRNSIssue of Equity
26th Nov 20137:00 amRNSASIC goes live with new surveillance system
5th Nov 20137:00 amRNSInterim Results
23rd Oct 20137:00 amRNSNotice of Results
30th Sep 20131:34 pmRNSTotal Voting Rights
18th Sep 20131:01 pmRNSCollaboration with NYSE Technologies
11th Sep 20137:00 amRNSEnterprise Securities Market Notice
10th Sep 20137:00 amRNSContract Win
5th Sep 20132:41 pmRNSIssue of Equity
30th Aug 20131:05 pmRNSTotal Voting Rights
21st Aug 20137:00 amRNSDelta Stream Selected by Communications Provider
14th Aug 20137:00 amRNSEnterprise Securities Market Notice
8th Aug 201312:53 pmRNSIssue of Equity
18th Jul 201312:55 pmRNSResult of AGM
9th Jul 20137:00 amRNSEnterprise Securities Market Notice
5th Jul 20134:11 pmRNSHolding(s) in Company
5th Jul 20134:10 pmRNSHolding(s) in Company
3rd Jul 20133:18 pmRNSIssue of Equity
3rd Jul 20137:00 amRNSEnterprise Securities Market Notice
28th Jun 20137:00 amRNSPlacing of 840,000 new ordinary shares
18th Jun 20137:00 amRNSFinal Results
5th Jun 20137:00 amRNSNotice of Results
9th May 20137:00 amRNSBoard restructuring
30th Apr 20138:00 amRNSTotal Voting Rights
26th Apr 20133:54 pmRNSEnterprise Securities Market Notice
23rd Apr 20137:00 amRNSEnterprise Securities Market Notice
19th Apr 20137:30 amRNSChange in Directors Shareholding
19th Apr 20137:30 amRNSGrant of Options
17th Apr 20133:10 pmRNSIssue of Equity
3rd Apr 20133:40 pmRNSDirector's Shareholding
2nd Apr 20137:00 amRNSPre-close period trading update
15th Mar 20137:00 amRNSSEF initiative & Compliance Officer appointment
28th Feb 20137:00 amRNSTotal Voting Rights
11th Feb 20137:00 amRNSEnterprise Securities Market Notice
6th Feb 20137:00 amRNSExercise of Options
4th Jan 20133:41 pmRNSDirector/PDMR Shareholding
13th Dec 20127:00 amRNSContract win
10th Dec 20127:00 amRNSDirectorate Change
30th Nov 20127:00 amRNSTotal Voting Rights
16th Nov 20127:00 amRNSEnterprise Securities Market Notice
14th Nov 20127:00 amRNSDirector shareholding
13th Nov 20127:00 amRNSDirector shareholding
12th Nov 20123:24 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.